| Jan 12 2024 |
12 Days of Handbook Updates: Remote Workers |
Barnes & Thornburg LLP |
| Jan 11 2024 |
Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 |
Schwegman, Lundberg & Woessner, P.A. |
| Jan 11 2024 |
FDA says 87 Adverse Events Linked to Recalled Applesauce |
Keller and Heckman LLP |
| Jan 11 2024 |
Heads-Up: Oral Phenylephrine Products, Advisories and Lawsuits |
Womble Bond Dickinson (US) LLP |
| Jan 11 2024 |
City of Pittsburgh to Strictly Enforce Paid Sick Days Ordinance, Investigate Food Service Industry |
Jackson Lewis P.C. |
| Jan 11 2024 |
GRAS: Are Changes in Our Future? — A Conversation with Karin F. Baron [PODCAST] |
Bergeson & Campbell, P.C. |
| Jan 11 2024 |
FDA: Major Policy Shift Authorizes Florida’s Plan to Import Drugs from Canada |
Foley & Lardner LLP |
| Jan 11 2024 |
Don’t Assume Sweet Success: Forum Selection Clause Doesn’t Preclude IPR |
McDermott Will & Schulte LLP |
| Jan 11 2024 |
Hopping Towards Change: New Jersey Proposes A Crafty New Solution to the Special Ruling |
Norris McLaughlin P.A. |
| Jan 10 2024 |
Contracts Corner: Sponsorship Agreements |
McDermott Will & Schulte LLP |
| Jan 10 2024 |
EU Corporate Sustainability Due Diligence Directive Nearly Final |
Hunton Andrews Kurth |
| Jan 10 2024 |
California Court Applies Proposition 65 Safe Harbor in Dismissal |
Keller and Heckman LLP |
| Jan 9 2024 |
MoCRA Update for Starting the Year Off Right |
Beveridge & Diamond PC |
| Jan 9 2024 |
FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious |
Keller and Heckman LLP |
| Jan 9 2024 |
5th Circuit Issues Blistering Critique of FDA’s Handling of PMTAs for E-Cigarettes |
Keller and Heckman LLP |
| Jan 9 2024 |
CORE Releases 2022 Annual Outbreak Report |
Keller and Heckman LLP |
| Jan 9 2024 |
Malta Initiative Survey on OECD Test Guidelines and Guidance Documents Will Close January 12 |
Bergeson & Campbell, P.C. |
| Jan 9 2024 |
Blazing Trails: Exploring ESOPs in the Cannabis Industry |
Bradley Arant Boult Cummings LLP |
| Jan 8 2024 |
Gold Dome Report – Legislative Day 1 (2024) |
Nelson Mullins |
| Jan 8 2024 |
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT |
Mintz |
| Jan 8 2024 |
Extended Producer Responsibility for Packaging: What’s Ahead in 2024 |
Hunton Andrews Kurth |
| Jan 5 2024 |
Trending in Telehealth: December 21, 2023 – January 3, 2024 |
McDermott Will & Schulte LLP |
| Jan 5 2024 |
Texas Urges Federal Court to Toss Tofurky Challenge of Labeling Law |
Keller and Heckman LLP |
| Jan 5 2024 |
McDermottPlus Check-Up: January 5, 2024 |
McDermott Will & Schulte LLP |
| Jan 5 2024 |
Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy |
Epstein Becker & Green, P.C. |
| Jan 4 2024 |
With Increased New York Minimum Wage Come Modified Obligations Under State Wage Orders |
Jackson Lewis P.C. |
| Jan 4 2024 |
2023: A Good Trip Around the Sun for Psychedelics |
Bradley Arant Boult Cummings LLP |
| Jan 4 2024 |
Not So Fast My Friend: Alabama Medical Commission Halts Issuance of Integrated (and Probably Dispensary) Licenses |
Bradley Arant Boult Cummings LLP |
| Jan 4 2024 |
Brand Selection Primer for Emerging Healthy F&B Companies |
Foley & Lardner LLP |
| Jan 4 2024 |
FDA Announces Availability of Cosmetics Direct Portal and Publication of Final Guidance on Cosmetic Facility Registration and Product Listing |
ArentFox Schiff LLP |
| Jan 4 2024 |
Acetaminophen MDL: Judge Excludes All of Plaintiffs’ Causation Experts Pursuant to Newly-Amended FRE Rule 702 |
Foley & Lardner LLP |
| Jan 4 2024 |
Espresso Yourself: When Prosecution History as a Whole Doesn’t Demonstrate Clear, Unmistakable Disclaimer |
McDermott Will & Schulte LLP |
| Jan 4 2024 |
Same Applicant, Similar Claims Support Obviousness-Type Double Patenting Rejection |
McDermott Will & Schulte LLP |
| Jan 3 2024 |
NIOSH Reviews Past Nanotechnology Guidance and Needs for Future Research |
Bergeson & Campbell, P.C. |
| Jan 3 2024 |
DOT Random Drug and Alcohol Testing Rates for 2024 |
Jackson Lewis P.C. |
